Jiye Liu

7PUBLICATIONS
37CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteinsGene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 29, 2024
Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myeloma.

Annamaria Gulla, Eugenio Morelli, Megan Johnstone

|Feb 14, 2024
Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myeloma.

Jiye Liu, Lijie Xing, Jiang Li

|Dec 10, 2023
BCMA-targeted bortezomib nanotherapy improves therapeutic efficacy, overcomes resistance, and modulates the immune microenvironment in multiple myeloma.

Debasmita Dutta, Jiye Liu, Kenneth Wen

|May 16, 2023
Targeting BCMA in Multiple Myeloma: Advances in Antibody-Drug Conjugate Therapy.

Lijie Xing, Yuntong Liu, Jiye Liu

|Feb 13, 2023
BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma.

Keiji Kurata, Mehmet K Samur, Priscilla Liow

|Jul 24, 2021
BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression.

Lijie Xing, Su Wang, Jiye Liu

Pageof 2

Frequent Collaborators

4 joint publications

Kenneth C Anderson

4 joint publications

Keiji Kurata

3 joint publications

Mehmet K Samur

3 joint publications

Yu-Tzu Tai